Erkki Ruoslahti

Erkki Ruoslahti

Founder at Cend Therapeutics, Inc.

Net worth: 4 M $ as of 30/03/2024

84 year
Health Technology
Commercial Services
Consumer Services

Profile

Erkki Ruoslahti is the founder of Telios Pharmaceuticals, Inc. (founded in 1987), Targeted Molecules Corp.
(founded in 2000), and Cend Therapeutics, Inc. (founded in 2015).
He holds the title of Director at Telios Pharmaceuticals, Inc. from 1987 to 1995, Director at Targeted Molecules Corp.
from 2000 to 2002, and previously served as the Executive Chairman at Cend Therapeutics, Inc. Dr. Ruoslahti is also the founder of FIBRX Derm, Inc., Center For Nanomedicine, and Impilo Therapeutics, Inc. Dr. Ruoslahti's current job(s) include being a Professor at the University of California, Berkeley, a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, a Member of the National Academy of Medicine (United States), and a Member of the European Molecular Biology Organization.
Dr. Ruoslahti's former job(s) include being the President & Chief Executive Officer of Sanford Burnham Prebys Medical Discovery Institute from 1976 to 2020, Director at Advance Technologies, Inc. from 2005 to 2008, Director at Canji, Inc. from 1993 to 1996, Independent Director at Astellas Institute for Regenerative Medicine from 2005 to 2011, Independent Director at Lisata Therapeutics, Inc. from 2022 to 2023, and Professor at the University of California, Santa Barbara from 2005 to 2015.
Dr. Ruoslahti obtained a doctorate degree from the University of Helsinki.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/04/2023 1,171,144 ( 14.10% ) 4 M $ 30/03/2024

Erkki Ruoslahti active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
University of California, Berkeley Corporate Officer/Principal 30/06/2011
Founder 31/12/2014
European Molecular Biology Organization Corporate Officer/Principal -
All active positions of Erkki Ruoslahti

Former positions of Erkki Ruoslahti

CompaniesPositionEnd
LISATA THERAPEUTICS, INC. Director/Board Member 10/07/2023
Chief Executive Officer 31/08/2020
Founder 31/08/2020
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Erkki Ruoslahti's experience

Training of Erkki Ruoslahti

University of Helsinki Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erkki Ruoslahti's experience

Connections

100 +

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
LISATA THERAPEUTICS, INC.

Health Technology

Private companies14

Health Technology

Advance Technologies, Inc.

Electronic Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Services

European Molecular Biology Organization

Health Technology

Health Technology

Technology Services

Center For Nanomedicine

See company connections
  1. Stock Market
  2. Insiders
  3. Erkki Ruoslahti